Merck announces FDA approval for two new drugs

By Sean Galea-Pace
The US-based pharmaceutical company, Merck, has announced Food and Drug Administration (FDA) approvals for two new drugs. The meds, Delstrigo and Pife...

The US-based pharmaceutical company, Merck, has announced Food and Drug Administration (FDA) approvals for two new drugs.

The meds, Delstrigo and Pifeltro, have been granted approval to treat patients with HIV-1 who haven’t had prior antiretroviral treatments, however, do not cure the HIV infection or AIDS.

According to the press release, “Delstrigo is to be taken once a day in a fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate while Pifeltro is a new non-nucleoside reverse transcriptase inhibitor to be administered in combination with other antiretroviral medicines.”

See more:

It has been revealed that the meds are to be contraindicated when co-administered with drugs that are strong cytochrome P450 3A enzyme inducers as substantial reductions in doravirine plasma concentrations are thought to occur, which is feared to reduce the impact of Delstrigo and Pifeltro.

Dr. George Hanna, vice president and therapeutic area head of infectious diseases, stated: “As part of Merck’s 30-year commitment to the care of people with HIV, we are pleased to now bring forward these two new antiretroviral treatment options, Delstrigo and Pifeltro, which we believe offer a compelling clinical profile for clinicians and people living with HIV.”

“We are thankful to the researchers as well as those living with HIV and their communities for the collaboration that made today’s approval possible.”

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI